974 related articles for article (PubMed ID: 25524389)
21. Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US.
Amin A; Deitelzweig S; Bucior I; Lin J; Lingohr-Smith M; Menges B; Neuman WR
J Med Econ; 2019 Nov; 22(11):1119-1125. PubMed ID: 31084383
[No Abstract] [Full Text] [Related]
22. Racial, biological sex, and geographic disparities of venous thromboembolism in the United States, 2016 to 2019.
Afifi AM; Leverich M; Tadrousse K; Ren G; Nazzal M
J Vasc Surg Venous Lymphat Disord; 2024 May; ():101908. PubMed ID: 38759751
[TBL] [Abstract][Full Text] [Related]
23. Policy Change for Deep Vein Thrombosis: Effects on Length of Stay and Hospitalization Costs of Moving From Warfarin to Direct Oral Anticoagulants.
Porath AD; Clodfelter S; Slaton T; Bookhart BK; Kozma CM; Rand ML; Bloch MJ
Clin Ther; 2019 Feb; 41(2):269-279. PubMed ID: 30642614
[TBL] [Abstract][Full Text] [Related]
24. Rate and impact of venous thromboembolism in patients with ST-segment elevation myocardial infarction: Analysis of the Nationwide Inpatient Sample database 2003-2013.
Al-Ogaili A; Ayoub A; Diaz Quintero L; Torres C; Fuentes HE; Fugar S; Kolkailah AA; Dakkak W; Tafur AJ; Yadav N
Vasc Med; 2019 Aug; 24(4):341-348. PubMed ID: 30915913
[TBL] [Abstract][Full Text] [Related]
25. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Bell GK; Goldhaber SZ
Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
[TBL] [Abstract][Full Text] [Related]
26. Economic burden of recurrent venous thromboembolism: analysis from a U.S. hospital perspective.
Casciano JP; Dotiwala Z; Kemp R; Li C; Cai J; Preblick R
Am J Health Syst Pharm; 2015 Feb; 72(4):291-300. PubMed ID: 25631836
[TBL] [Abstract][Full Text] [Related]
27. Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in China.
Wu EQ; Xie J; Wu C; Du EX; Li N; Tan R; Liu Y
Pharmacoeconomics; 2014 Mar; 32(3):305-13. PubMed ID: 24500859
[TBL] [Abstract][Full Text] [Related]
28. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
[TBL] [Abstract][Full Text] [Related]
29. Risk of venous thromboembolism among hospitalized medically ill patients.
Edelsberg J; Hagiwara M; Taneja C; Oster G
Am J Health Syst Pharm; 2006 Oct; 63(20 Suppl 6):S16-22. PubMed ID: 17032930
[TBL] [Abstract][Full Text] [Related]
30. Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism.
van Bellen B; Bamber L; Correa de Carvalho F; Prins M; Wang M; Lensing AW
Curr Med Res Opin; 2014 May; 30(5):829-37. PubMed ID: 24432872
[TBL] [Abstract][Full Text] [Related]
31. Cost of Treating Venous Thromboembolism With Heparin and Warfarin Versus Home Treatment With Rivaroxaban.
Kahler ZP; Beam DM; Kline JA
Acad Emerg Med; 2015 Jul; 22(7):796-802. PubMed ID: 26111453
[TBL] [Abstract][Full Text] [Related]
32. Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.
Erben Y; Franco-Mesa C; Gloviczki P; Stone W; Quinones-Hinojoas A; Meltzer AJ; Lin M; Greenway MRF; Hamid O; Devcic Z; Toskich B; Ritchie C; Lamb CJ; De Martino RR; Siegel J; Farres H; Hakaim AG; Sanghavi DK; Li Y; Rivera C; Moreno-Franco P; O'Keefe NL; Gopal N; Marquez CP; Huang JF; Kalra M; Shields R; Prudencio M; Gendron T; McBane R; Park M; Hoyne JB; Petrucelli L; O'Horo JC; Meschia JF
J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1361-1370.e1. PubMed ID: 33836287
[TBL] [Abstract][Full Text] [Related]
33. The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK.
Jugrin AV; Ustyugova A; Urbich M; Lamotte M; Sunderland T
Thromb Haemost; 2015 Oct; 114(4):778-92. PubMed ID: 26272227
[TBL] [Abstract][Full Text] [Related]
34. Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample.
Park B; Messina L; Dargon P; Huang W; Ciocca R; Anderson FA
Chest; 2009 Oct; 136(4):983-990. PubMed ID: 19525357
[TBL] [Abstract][Full Text] [Related]
35. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery.
Baser O; Supina D; Sengupta N; Wang L; Kwong L
Am J Health Syst Pharm; 2010 Sep; 67(17):1438-45. PubMed ID: 20720243
[TBL] [Abstract][Full Text] [Related]
36. Burden of illness in venous thromboembolism in critical care: a multicenter observational study.
Patel R; Cook DJ; Meade MO; Griffith LE; Mehta G; Rocker GM; Marshall JC; Hodder R; Martin CM; Heyland DK; Peters S; Muscedere J; Soth M; Campbell N; Guyatt GH; ;
J Crit Care; 2005 Dec; 20(4):341-7. PubMed ID: 16310605
[TBL] [Abstract][Full Text] [Related]
37. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
[TBL] [Abstract][Full Text] [Related]
38. Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
Wenger N; Sebastian T; Beer JH; Mazzolai L; Aujesky D; Hayoz D; Engelberger RP; Korte W; Voci D; Kucher N; Barco S; Spirk D
Thromb Res; 2022 Dec; 220():65-71. PubMed ID: 36272334
[TBL] [Abstract][Full Text] [Related]
39. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
Huse DM; Cummins G; Taylor DC; Russell MW
Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346
[TBL] [Abstract][Full Text] [Related]
40. Real-world rates of in-hospital and postdischarge deep-vein thrombosis and pulmonary embolism in at-risk medical patients in the United States.
Amin AN; Lin J; Thompson S; Wiederkehr D
Clin Appl Thromb Hemost; 2011; 17(6):611-9. PubMed ID: 21593021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
